Advanced Biomed (ADVB) Research & Development (2023 - 2026)

Advanced Biomed has reported Research & Development for 4 years, with the latest figure at $243226.0 in Q1 2026.

• Quarterly Research & Development rose 10.57% year-over-year to $243226.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $975264.0 (up 18.48% YoY) and the FY2025 annual result came in at $909771.0, up 3.36% from the prior year.
• Research & Development grew to $243226.0 in Q1 2026 per ADVB's latest filing, from $186331.0 in the prior quarter.
• Over five years, Research & Development peaked at $313509.0 in Q1 2024 and troughed at $181703.0 in Q3 2024.
• A 4-year average of $230033.8 and a median of $216181.5 in 2024 frame the typical range for Research & Development.
• The widest YoY moves for Research & Development: up 48.11% in 2025, down 29.84% in 2025.
• Over 4 years, Research & Development stood at $188387.0 in 2023, then gained by 12.75% to $212397.0 in 2024, then dropped by 12.27% to $186331.0 in 2025, then surged by 30.53% to $243226.0 in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $243226.0, $186331.0, and $235992.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.